If past is prologue, HMOs will make a comeback in Indiana
WellPoint created an HMO joint venture with seven big hospitals in Los Angeles. Could it do something similar here? Quite possibly.
Life Science & Biotech
Articles
The pain (and pleasure) that comes from paying more of our health care bills
Paying off medical debts over time is now a common experience for families with health insurance and becoming more so. And that is inducing big changes in the health care marketplace.
Why small firms have been irate about health insurance
For Indiana employers with fewer than 10 workers, health insurance premiums have risen 11.5 percent, on average, from 2001 to 2013. That ranked second-highest among all states.
What if hospitals ‘upcharged’ you for being fat?
As local hospitals try to offer package deals with upfront prices on joint replacement surgeries, they're struggling with the reality that patients' other health conditions can significantly increase their cost of care.
USDA approves new modified corn, soybean seeds
The farmers won't be able to take full advantage of the seeds until the EPA issues a second ruling allowing the use of weed killer Enlist. The EPA has said it will rule this fall on Indianapolis-based Dow AgroSciences' application to market the chemical.
HOHMANN: Whatever happened to the fab 16 Tech?
Strong leadership is needed for the urban Indianapolis tech park to hit its high potential.
Obamacare exchanges boosted coverage, premiums and spending in Indiana
A new study finds that Obamacare boosted enrollment in Indiana’s individual insurance market significantly over what it would have been without the law, but also caused premiums to spike.
Recent wins worth $4B to Lilly market value
Lilly is finally putting meat on the bones of its predictions about its experimental diabetes and cancer drugs. That gives investors the certainty they crave that Lilly’s future revenue won’t remain in its 2014 doldrums.
Lilly cancer drug fares well in late-stage study
Eli Lilly and Co. said Friday its potential colorectal cancer drug Cyramza helped patients on chemotherapy with advanced cases of the disease survive longer than patients on chemotherapy alone.
Conservatives swinging Pence’s way on health reform
Conservatives, after waging war on Obamacare, including its large expansion of Medicaid, are starting to try to propose alternative, conservative ways to achieve its key goals.
Startup Companion Diagnostics trying to work through bankruptcy
Companion Diagnostics Inc., a biotech company that relocated to Indiana from Connecticut in 2010, has entered bankruptcy reorganization while it tries to develop a therapy for inflammation.
While national health care spending growth slowed, Indiana accelerated
Indiana does not appear to be enjoying the rest of the nation’s slowdown in health care spending. Year-to-year growth in Indiana hit 6 percent in 2012 versus 4.5 percent for the nation.
Feds: AIT’s Evans ‘unjustly enriched’ himself in sale to employees
Just three months before the parent company of AIT Laboratories was sold in 2009 to its employees for $90 million, it was appraised for $17.1 million, according to a U.S. Department of Labor lawsuit.
Indiana has too many nursing homes
Indiana has 58 percent more nursing homes per resident and spends an extra $1 billion per year on care in nursing homes than the average for the rest of the country.
Patients, providers respond after Anthem promotes lower-cost MRI facilities
Anthem patients in five U.S. cities, including Indianapolis, spent $220 less per MRI scan after Anthem told them of lower-cost facilities. In response, hospital-owned MRI facilities cut their prices.
Lilly wins tentative approval for diabetes drug
Final approval could be delayed until mid-2016 due to a claim of patent infringement by drugmaker Sanofi.
Indiana’s tax breaks for jobs cost at least three times more than Medicaid expansion
State and local governments hand out $921 million per year to entice business to add jobs. The Medicaid expansion is estimated to cost no more than $279 million per year.
Is this the future of rural health care: Walmart, walk-in clinics and an ambulance?
In two to three years, primary care clinics could be popping up in Walmart stores in rural Indiana while most rural Indiana hospitals will offer little to no inpatient services. That’s dramatically different from what we’re used to.
Biotech comeback: Eli Lilly making renewed push in lucrative field it once pioneered
Lilly expects to soon announce late-stage clinical trial results for two biotech drugs designed to slow the inflammation caused by autoimmune diseases. By the end of the year, it will announce results for a third.